Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IICompletedNov 2, 2022Quinapril and Hydrochlorothiazide TabletsCGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.Aurobindo Pharma USA Inc. · D-0021-2023Class IITerminatedNov 2, 2022Fondaparinux Sodium InjectionSubpotent Drug: Out of specification for assayAuroMedics Pharma LLC · D-0020-2023Class ITerminatedNov 2, 2022Atenolol TabletsLabel Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg TabletsGolden State Medical Supply Inc. · D-0019-2023Class IITerminatedNov 2, 2022Pyridostigmine Bromide Oral SolutioncGMP Deviations: Out of specification for assay of one of the preservative ingredients.VistaPharm, Inc. · D-0018-2023Class IITerminatedNov 2, 2022Proton ArmorChemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.Ultra Chem Labs Corp · D-0017-2023Class IITerminatedNov 2, 2022Proton ArmorChemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.Ultra Chem Labs Corp · D-0016-2023Class IIOngoingOct 26, 20220.9% Sodium Chloride InjectionLack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.Fresenius Medical Care Holdings, Inc. · D-0015-2023Class IIITerminatedOct 26, 2022NDC 0363-6171-09 Walgreens Sinus PressureBoxes mislabeled to read "Decongestant Free", but the product contains Phenylephrine HCI 5mgLNK International, Inc. · D-0014-2023Class IICompletedOct 26, 2022Acyclovir Sodium InjectionPresence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.AuroMedics Pharma LLC · D-0013-2023Class IITerminatedOct 26, 2022Rifampin CapsulesFailed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).Golden State Medical Supply Inc. · D-0012-2023Class IITerminatedOct 26, 2022Rifampin CapsulesFailed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).Golden State Medical Supply Inc. · D-0011-2023Class IICompletedOct 26, 2022Flunisolide Nasal SolutionOut of specification for related substances (impurities).Ingenus Pharmaceuticals Llc · D-0010-2023Class IITerminatedOct 19, 2022Skincell Mole & Skin Corrector SerumMarketed Without An Approved NDA/ANDA; Unapproved new drugJustified Laboratories · D-0009-2023Class IITerminatedOct 19, 2022Skincell Mole & Skin Corrector SerumMarketed Without An Approved NDA/ANDA; Unapproved new drugJustified Laboratories · D-0008-2023Class IIIOngoingOct 12, 2022Tranexamic Acid InjectionPresence of Particulate Matter: Piece of metal found in a vialAuroMedics Pharma LLC · D-1551-2022Class IITerminatedOct 12, 2022Arformoterol Tartrate Inhalation SolutionLack of Assurance of Sterility: environmental monitoring failure.Cipla · D-1550-2022Class IIICompletedOct 12, 2022Phytonadione Injectable Emulsion USPFailed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.Dr. Reddy's Laboratories, Inc. · D-0007-2023Class IIITerminatedOct 12, 2022Antibacterial Foaming Wash with Hydria Moisturizing FormulaLabeling: Not Elsewhere Classified - Incorrect label-incorrect scent listed on label.Woodbine Products Co Inc · D-0006-2023Class IITerminatedOct 12, 2022Aminophylline InjectionPresence of Particulate Matter: A complaint was received for the presence of a hair in one vial.Pfizer Inc. · D-0003-2023Class ITerminatedOct 12, 2022Antica Farmacista Hand Sanitizer Ocean CitronChemical Contamination: product found to contain benzeneSalon Technologies International Inc · D-0002-2023Class IITerminatedOct 12, 2022Sanitizing Hand Spray 80%GMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.Salon Technologies International Inc · D-0001-2023Class IIITerminatedOct 5, 2022XolegelFailed Viscosity specification: Slightly higher OOS results obtained for viscosityAlmirall, LLC · D-1549-2022Class IIOngoingOct 5, 2022Rifampin CapsulesFailed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).Akorn, Inc. · D-1548-2022Class IIOngoingOct 5, 2022Rifampin CapsulesFailed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).Akorn, Inc. · D-1547-2022Class IIITerminatedOct 5, 2022ClomiPRAMINE Hydrochloride CapsulesSuperpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsulesLeading Pharma, LLC · D-1546-2022Class IITerminatedOct 5, 2022Budesonide Inhalation Suspension 0.25mg/2mLLack of Assurance of SterilityCipla · D-1545-2022Class IIITerminatedOct 5, 2022oxyTOCIN 30 Units/500 mLIncorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).QuVa Pharma, Inc. · D-1544-2022Class IITerminatedOct 5, 2022Neoral soft gelatin capsulesCGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.Novartis Pharmaceuticals Corporation · D-1543-2022Class IITerminatedOct 5, 2022Ampicillin for InjectionPresence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.Viatris Inc · D-1542-2022Class IIITerminatedOct 5, 2022Esomeprazole Magnesium Delayed-Release CapsulesSuperpotent Drug: Out of specification for assay at the 12-month timepoint.Sun Pharmaceutical Industries Inc · D-0005-2023Class IIITerminatedOct 5, 2022Esomeprazole Magnesium Delayed-Release CapsulesSuperpotent Drug: Out of specification for assay at the 12-month timepoint.Sun Pharmaceutical Industries Inc · D-0004-2023Class IIITerminatedSep 28, 2022Clonidine Hydrochloride TabletsProduct mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,Unichem Pharmaceuticals USA Inc · D-1541-2022Class ITerminatedSep 21, 2022PROPOFOL Injectable EmulsionPresence of particulate matterPfizer Inc. · D-1540-2022Class IITerminatedSep 21, 2022Dextroamphetamine SaccharateLabeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.Teva Pharmaceuticals USA Inc · D-1539-2022Class IITerminatedSep 21, 2022Lisinopril 10 mg tabletsPresence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.RemedyRepack Inc. · D-1538-2022Class IITerminatedSep 21, 2022Synergy Hand SanitizerCGMP Deviations: FDA analysis found product to contain acetaldehyde impurity and the Sum of All Impurities, above specification limits.Superior Glove Works, Ltd. · D-1537-2022Class IITerminatedSep 21, 2022Lisinopril Tablets USPPresence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.Lupin Pharmaceuticals Inc. · D-1536-2022Class IICompletedSep 21, 2022Triamcinolone Acetonide creamCGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.Direct Rx · D-1535-2022Class IICompletedSep 21, 2022QUAD-MIX 30MG/3MG/60MCG/0.2 InjectableLack of Assurance of SterilityCarolina Infusion · D-1534-2022Class IICompletedSep 21, 2022QUAD-MIX 30/2/60/0.15 InjectableLack of Assurance of SterilityCarolina Infusion · D-1533-2022

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.